<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Van Campen, J.S.J.A.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Bisoprolol Improves RVEF and Heart Rate in PAH</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">21-21</style></pages><abstract><style  face="normal" font="default" size="100%">Treatment of idiopathic pulmonary arterial hypertension (PAH) with the β-blocker bisoprolol resulted in decreased heart rate, increased right ventricular ejection fraction (RVEF), and improved quality of life. This article presents data from the Beta-Blocker Therapy in Idiopathic Pulmonary Arterial Hypertension trial [NCT01246037; Van Campen JSJA et al. Am J Respir Crit Care 2014].</style></abstract><number><style face="normal" font="default" size="100%">11</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>